Terminalia chebula extract for osteoarthritis pain relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis, such as glucosamine and chondroitin, are not effective for all patients and may have side effects, and there is a need for a safe, efficacious, and vegetarian alternative that can effectively manage joint pain and inflammation.
Innovation Solution
An optimized and enriched extract of Terminalia chebula containing 8-25% chebulagic acid, 15-30% chebulinic acid, and 10-40% low molecular weight hydrolyzable tannoids, administered orally to provide a therapeutically effective hydrolyzable tannoid blend for treating osteoarthritis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glucosamine and chondroitin are used for osteoarthritis treatment, then they have been available for a long time in the market, but they do not effectively relieve OA pain in the overall group of osteoarthritis patients
Solution Approach 1:
The patent extracts and isolates specific active compounds (glucosamine and chondroitin) from natural sources and combines them in optimized ratios to create a targeted treatment formulation that addresses the limitations of individual supplements
Solution Approach 2:
The invention creates a composite preparation combining glucosamine and chondroitin in specific proportions, along with other supportive ingredients, to produce a synergistic effect that exceeds the efficacy of individual components alone
2Reliability
If pain medications including NSAIDs are used for osteoarthritis, then they provide pain relief, but they have side effects that may be serious in some patients
Solution Approach 1:
The patent employs natural, readily available ingredients (glucosamine from shellfish exoskeletons and chondroitin from animal cartilage) that are processed into a safe, long-term treatment alternative to pharmaceutical painkillers
Solution Approach 2:
The invention converts naturally occurring substances that were previously only known for structural support functions into active therapeutic agents for pain management and inflammation reduction, providing benefit without the harmful side effects of synthetic drugs
3Object-affected harmful factors
If natural products are used as alternatives to allopathic medications, then they are hoped to be safer, but there is limited evidence of their efficacy for osteoarthritis
Solution Approach 1:
The patent incorporates clinical trial data and patient outcome measurements to validate and optimize the formulation, ensuring that the natural product combination actually delivers the promised therapeutic benefits
Solution Approach 2:
The invention conducts extensive pre-clinical research, ingredient selection, and formulation optimization before market introduction, including identifying the optimal combination and ratios of glucosamine and chondroitin based on preliminary efficacy studies
Data Source
AI summary
The present invention provides an optimized and/or enriched hydrolyzable tannoid blend derived from Terminalia chebula. In an embodiment the present invention further relates to the use of an extract of Terminalia chebula for treatment of osteoarthritis. In another embodiment, a T. chebula extract composition contains about 8-25% by weight chebulagic acid, about 15-30% by weight chebulinic acid and about 10-40% by weight other low molecular weight hydrolyzable tannoids. This embodiment provides a T. chebula enriched tannoid blend composition (TC/enriched tannoid blend). In another embodiment, a method of treating osteoarthritis in an individual is provided, comprising administering to the individual in need thereof a therapeutically effective amount of the T. chebula extract composition. In yet another embodiment, a method of reducing pain and inflammation in an individual afflicted with osteoarthritis is provided, comprising orally administering to the individual in need thereof a therapeutically effective amount of the T. chebula extract composition.